A novel conditionally replicating adenoviral vector with dual expression of IL-24 and arresten inserted in E1 and the region between E4 and fiber for improved melanoma therapy.
about
Exploiting tumor epigenetics to improve oncolytic virotherapyPotent anti-tumour activity of a novel conditionally replicating adenovirus for melanoma via inhibition of migration and invasion.Therapeutic improvement of a stroma-targeted CRAd by incorporating motives responsive to the melanoma microenvironmentConstruction and characterization of E1- and E3-deleted adenovirus vectors expressing two antigens from two separate expression cassettes.Update on oncolytic viral therapy - targeting angiogenesisOncolytic virotherapy for urological cancers.
P2860
A novel conditionally replicating adenoviral vector with dual expression of IL-24 and arresten inserted in E1 and the region between E4 and fiber for improved melanoma therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
A novel conditionally replicat ...... for improved melanoma therapy.
@en
A novel conditionally replicat ...... for improved melanoma therapy.
@nl
type
label
A novel conditionally replicat ...... for improved melanoma therapy.
@en
A novel conditionally replicat ...... for improved melanoma therapy.
@nl
prefLabel
A novel conditionally replicat ...... for improved melanoma therapy.
@en
A novel conditionally replicat ...... for improved melanoma therapy.
@nl
P2093
P2860
P356
P1433
P1476
A novel conditionally replicat ...... for improved melanoma therapy
@en
P2093
P2860
P2888
P304
P356
10.1038/CGT.2011.84
P50
P577
2011-12-23T00:00:00Z